BTMD (biote.com) Business Value to Revenue

biote Corp (BTMD) - corporate logo

How can revenue predictability be ensured amidst market volatility? The enterprise value-to-revenue multiple illustrates the current trend, where the value 971.21 captures the metric level. Recurring patient payments for hormone therapy stabilize the cash flow of biote Corp. (BTMD). High margins and franchising generate excess liquidity, while the development of a network of trained clinics with attractive physician bonuses guarantees expansion within the B2B segment.

biote Corp (BTMD) Enterprise Value-to-Revenue Ratio: for the period 11/23/2025 - 11/20/2026

BTMD (biote Corp): analytical breakdowns and indicator data

- price and consensus price forecast:
- business market valuation indicators:
Fundamental valuation:BTMD (biote Corp.)
Product sample of biote.com

An investment audit of the issuer requires separating market noise from the actual value of assets. The EV/Sales metric compares the total enterprise value, including debt minus cash, against annual revenue. For biote Corp. (BTMD), this calculation reflects the monetization efficiency of hormone therapy and ESG initiatives. An upward trajectory of the EV/Sales multiple signals inflated market expectations, while sharp deviations along this path warn of a potential price correction risk.

Competitor analysis for biote Corp.

Enterprise Value-to-Revenue Multiple hcahealthcare.com|THC: EV/Sales Multiple|FMS - Total Company Value-to-Revenue Ratio|Company Value to Revenue SOLV|Encompass (EHC) - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Universal Health Services, Inc. (UHS)|DaVita Inc. - Company Value to Revenue Ratio|Enterprise Value-to-Revenue Ratio RadNet Corp RDNT|EV/Sales Multiple Option Care OPCH|Surgery Partners Inc - EV/Sales Multiple|PINC (Premier Corp) - Company Value to Revenue Ratio|nationalvision.com (EYE) - Enterprise Value-to-Revenue Ratio|Company Value to Revenue Progyny|Company Value to Revenue ARDT|EV/Sales Multiple Select Medical Corporation|Company Value to Revenue ASTH (Astrana Health)|Company Value to Revenue Pediatrix MD|U.S. Physical Therapy - Company Value to Revenue|Business Value to Revenue PNTG|Organogenesis - EV/Sales Multiple|NUTX (Nutex Health) - Company Value to Revenue Ratio|AUNA (Auna) - Company Value to Revenue|Enterprise Value to Sales Volume SBC (SBC Medical Group Holdings)|Enterprise Value-to-Revenue Ratio Evolus, Inc.|Community Health Systems, Inc. (CYH) - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Beauty Health (SKIN)|MediWound, Ltd. - Company Value to Revenue Ratio|The Joint Chiropractic - Company Value to Revenue|Enterprise Value-to-Revenue Coefficient DCGO (DocGo, Inc)|Total Company Value-to-Revenue Ratio PIII (p3hp.org)|GANX (Gain Therapeutics) - Company Value to Revenue Ratio|euda.com (EUDA) - Enterprise Value-to-Revenue Ratio|Company Value to Revenue Basel Medical|CLGN (CollPlant Biotechnologies) - EV/Sales Multiple|EV/Sales Multiple Cuprina Holdings Limited|Enterprise Value-to-Revenue Ratio concordmedical.com (CCM)|Enterprise Value-to-Revenue Ratio AMS (American Shared Hospital)|Enterprise Value-to-Revenue Ratio MEDIROM Corp MRM|EV/Sales Multiple avalon-globocare.com ALBT|DHAI - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio Longevity Health Holdings XAGE|NIVF (NewGenIvf Group Limited) - Company Value to Revenue|ATI Physical Therapy Inc. - Business Value to Revenue|CMAX (caremax.com) - EV/Sales Multiple|KDLY (Kindly MD Inc) - Enterprise Value-to-Revenue Coefficient|Enterprise Value-to-Revenue Ratio ModivCare Corp (MODV)|Total Company Value-to-Revenue Ratio Novo Integrated Sciences|SunLink Health Systems, Inc. - Company Value to Revenue|imacholdings.comm (BACK) - Enterprise Value-to-Revenue Multiple